|
Match
|
Document |
Document Title |
|
|
6703039 |
Reversible gelling system for ocular drug delivery
The invention provides an ophthalmic aqueous composition for topical administration, comprising: (a) a block copolymer of propylene oxide and ethylene oxide in concentration sufficient to provide...
|
|
|
6703045 |
Composition and method for maintaining blood glucose level
A composition useful for reducing serum glucose levels by an oral controlled release system and a method for treating diabetes in a human being by controlling the blood glucose level (BGL) and...
|
|
|
RE38459 |
Emulsion stability
An injectable physiologically acceptable aqueous phase fluorocarbon emulsion, which has substantially no free fluorocarbon, has an excellent stability is prepared by a process of the invention....
|
|
|
6699493 |
Method for reducing or preventing transplant rejection in the eye and intraocular implants for use therefor
Methods for reducing or preventing transplant rejection in the eye of an individual are described, comprising: a) performing an ocular transplant procedure; and b) implanting in the eye a...
|
|
|
6696067 |
Cosmetic compositions containing dispersion polymers
A cosmetically acceptable composition for treating hair, skin and nails comprising from about 0.001 to about 25 weight percent, based on polymer solids, of a stable dispersion in an aqueous salt...
|
|
|
6696500 |
Sustained-release preparation
A sustained-release preparation comprising a bioactive substance having an acidic group and a biodegradable polymer having an optionally protected basic group which improves the rate of...
|
|
|
6692767 |
Solid solution beadlet
Disclosed is a beadlet comprising (i) a hydrophobic long chain fatty acid or ester material; (ii) a surfactant; and (iii) a therapeutic agent which in admixture form a solid solution at room...
|
|
|
6689340 |
Hair composition containing a polycondensate comprising at least one polyurethane and/or polyurea unit and a polyol
The invention relates to hair compositions packaged in aerosol form and comprising, in a cosmetically acceptable medium, a polycondensate, such as a multiblock polymer, comprising at least one...
|
|
|
6680051 |
Functionalized polymers
Polymers containing amino acid and/or polypeptide moieties in their backbones or pendant to their backbones are made by metathesis. A method of making an amino acid or polypeptide containing...
|
|
|
6680065 |
Shaped bodies which release agrochemical active substances
The present invention relates to shaped articles which release agrochemical active compounds, are used for treatment of woody plants and are employed in a hollow preformed in the woody plant,are of...
|
|
|
6676971 |
Embolic compositions
Embolic compositions comprising macromers having a backbone comprising a polymeric backbone comprising units with a 1,2-diol or 1,3-diol structure, such as polyvinyl alcohol, and pendant chains...
|
|
|
6673767 |
Gel composition and methods
Methods and compositions for systemically or locally administering by implantation a beneficial agent to a subject are described, and include, for example, compositions having burst indices of 8 or...
|
|
|
6673365 |
Formulation for treatment of thromboembolism
A new pharmaceutical formulation comprising the thrombin inhibitor HOOC—CH2—(R)-Cgl-Aze-Pab in combination with medium chain glycerides, a process for the preparation of such a pharmaceutical for...
|
|
|
6673362 |
Resorbable barrier micro-membranes for attenuation of scar tissue during healing
Resorbable polylactide polymer scar tissue reduction barrier membranes and methods of their application are disclosed. The scar-tissue reduction barrier membranes are constructed entirely of...
|
|
|
6669966 |
Compositions for facilitating skin growth and methods and articles using same
Skin-growth-enhancing compounds and compositions including a therapeutically effective amount of at least one electron active compound, or a pharmaceutically acceptable derivative thereof, that has...
|
|
|
6664213 |
Liquid pesticide composition
A novel liquid pesticide composition comprising a pesticidally active ingredient and a polyoxyethylene alkyl ether which has the following features (a) and (b): (a) an HLB value of 6 to 13.5; and...
|
|
|
6660296 |
Sustained-release microgranules containing diltiazem as active principle
Novel forms of sustained-release microgranules (LP) containing diltiazem are disclosed. The microgranules consist of a neutral granular carrier coated with an active layer including diltiazem or a...
|
|
|
6660382 |
Process for manufacturing coated granules with masked taste and immediate release of the active principle
The invention concerns a method for making coated granules with masked taste and instant release of the active principle which consists in: first, mixing the constituents of a powder comprising at...
|
|
|
6660776 |
Composition and method for lubricating and protecting the oral cavity using flavored petroleum jelly
A composition and method for lubricating and protecting the oral cavity generally and specifically the teeth, gums and tongue using a flavored petrolatum. In the preferred embodiment, the...
|
|
|
6660300 |
Method of use of a biphasic controlled release delivery system for high solubility pharmaceuticals and method
A biphasic controlled release delivery system for pharmaceuticals which have high water solubility, such as the antidiabetic metformin HCl salt, is provided which provides a dosage form that has...
|
|
|
6660281 |
Silicones for power treatment powers having surface treated with said silicones and cosmetic materials containing said powers
Powders treated with silicones represented by the following formula (1): R1aR2bR3cSiO(4−a−b−c)/2 (1)whereinR1, R2, R3 a, b and c are as defined herein, are suitable for use in cosmetic materials.
|
|
|
6660775 |
Method and compositions for inhibiting the scent tracking ability of biting midges
The ability of biting midges to locate a target by olfactory emissions of the target is inhibited by dispensing into a spatial area an inhibiting effective amount of at least one inhibiting...
|
|
|
6660301 |
Injectable microspheres for dermal augmentation and tissue bulking
The present invention relates to elastic, hydrophilic and substantially spherical microspheres useful for dermal augmentation and tissue bulking. The invention provides injectable compositions...
|
|
|
6656487 |
Composition containing fibers and a dispersing copolymer
The invention relates to a composition containing fibers and a copolymer comprising carboxylate groups and polydimethylsiloxane groups. The composition according to the invention may especially...
|
|
|
6652883 |
Tissue bulking and coating compositions
Compositions comprising macromers having a backbone comprising units having a 1,2-diol and/or 1,3-diol structure for tissue bulking and coating. Such polymers include poly(vinyl alcohol) (PVA) and...
|
|
|
6652886 |
Biodegradable cationic copolymers of poly (alkylenimine) and poly (ethylene glycol) for the delivery of bioactive agents
A biodegradable, novel cationic coopolymer comprising a a poly(alkylenimine)(PAI), a hydrophilic polymer, and a biodegradable linker, wherein the biodegradable linker covalently links the PAI and...
|
|
|
6649174 |
Dual phase cosmetic composition
The present invention relates to a liquid dual phase cosmetic or pharmaceutical composition comprising an oil phase and an aqueous phase, the composition containing as a demixing agent a film...
|
|
|
6645913 |
Adjuvant composition
An adjuvant composition for pesticide formulations which exhibits reduced eye irritancy is comprised of a polyoxyalkylene aliphatic amine containing at least about 2 moles of an alkylene oxide...
|
|
|
6646011 |
Insect repellant compositions
The present invention relates to insect repellant compositions containing, based upon the total weight of the composition, from about 6 to about 30 percent by weight of insect repellant active...
|
|
|
6645476 |
Water-soluble polymers and their use in cosmetic and pharmaceutical compositions
The invention provides water-soluble polymers preparable by free-radical copolymerization of A) one or more macromonomers containing an end-group capable of polymerization, a hydrophilic moiety...
|
|
|
6641834 |
Compositions containing alpha-2-adrenergic agonist components
Compositions useful for improving effectiveness of alpha-2-adrenergic agonist components include carrier components, alpha-2-adrenergic agonist components, solubility enhancing components which aid...
|
|
|
6641833 |
Methods for treating ovarian cancer, poly (phosphoester) compositions, and biodegradable articles for same
Biodegradable polymer compositions suitable for intraperitoneal administration to treat a mammalian subject having ovarian cancer are described, wherein the polymer compositions provide extended...
|
|
|
6641800 |
Pressurized aerosol compositions comprising powdered medicament dispersed in hydrofluoroalkane
Pressurized aerosol composition for administration by inhalation comprising a liquefied hydrofluoroalkane, a powdered medicament dispersed therein, and a suspending agent comprising a polymer...
|
|
|
6641823 |
Make-up composition for the skin
A make-up cosmetic composition for the skin comprising, in a cosmetically acceptable aqueous medium, at least one film-forming polymer, at least one nonionic surfactant, and at least one...
|
|
|
6641831 |
Medical products with sustained pharmacological activity and process for producing them
A non-degradable medical product comprising at least two substances or groups of substances, of which a first substance is referred to as substance A and a second is referred to as substance B,...
|
|
|
6642276 |
Controlled release macrolide pharmaceutical formulations
Disclosed is an oral controlled release macrolide pharmaceutical formulation. In a preferred embodiment, the formulation comprises a citrate salt of a preferred macrolide, clarithromycin. Also...
|
|
|
6638499 |
Terminally-branched polymeric linkers and polymeric conjugates containing the same
The present invention is directed to polymeric-prodrug transport forms of the formula: wherein:E1-4 are independently selected from the group consisting of hydrogen, C1-6 alkyls, C3-12 branched...
|
|
|
6635281 |
Gastric retaining oral liquid dosage form
The present invention is directed to an active agent dosage form which is adapted for retention in the stomach and useful for the prolonged delivery of a liquid, active agent formulation to a fluid...
|
|
|
6632845 |
Method for improving muscle control and muscle tone and improving sensory integration
A method for improving muscle control, muscle tone, and sensory integration of an individual by applying polyacrylamide gel to the skin overlying the target muscles. A reflex response by the...
|
|
|
6630155 |
Controlled release liquid delivery compositions with low initial drug burst
The invention provides a controlled release polymeric composition which includes a base polymer or copolymer, an organic solvent, a polymeric controlled release additive, and a biologically active...
|
|
|
6630170 |
Mesoporous compositions and method of preparation
The present invention encompasses novel mesoporous compositions comprising vitamin E, and methods for their synthesis. The mesoporous compositions are synthesized in a range of conditions to...
|
|
|
6630458 |
Teat dipping agent
Use of a composition comprising chitosan in combination with a polysaccharide selected from heparin, heparan sulphate and dextran sulphate, as an active component in a solvent, for the manufacture...
|
|
|
6627217 |
External preparation
The present invention is a preparation for external use which contains a basic drug, polyvinyl pyrrolidone and a carboxyvinyl polymer and which has a pH of 4 to 9. The present invention has made it...
|
|
|
6627603 |
Method for releasing an active principle contained a multiple emulsion
A method for the controlled release of an active principle contained in a multiple water-in-oil-in-water emulsion characterized in that the multiple emulsion comprises an invert emulsion Ei with an...
|
|
|
6627209 |
Surgical stent and method for preventing occlusion of stented vessels and conduits after implantation of stents
The invention is of the design for, and a method of use of, an improved surgical stent. The stent is coated with a slow-release calcium channel blocker agent which interrupts the accumulation or...
|
|
|
6627210 |
Compositions containing α-2-adrenergic agonist components
Compositions useful for improving effectiveness of alpha-2-adrenergic agonist components include carrier components, alpha-2-adrenergic agonist components, solubility enhancing components which aid...
|
|
|
6627600 |
Compressed microparticles for dry injection
The invention relates to a pharmaceutical implant for controllably releasing a drug in a subject and methods for manufacturing and administering the implant. The implant is made of associated...
|
|
|
6627224 |
Low dose entecavir formulation and use
Compositions containing a low dose of entecavir are administered on a daily basis to treat hepatitis B virus infection and/or co-infections. Formulations for the oral administration of a low dose...
|
|
|
6623732 |
Pharmaceutical formulation for nasal administration
This invention discloses a pharmaceutical formulation for nasal administration which contains a pharmaceutically active polypeptide and a method producing the pharmaceutical formulation. The...
|
|
|
6624203 |
Nucleic acid bases used in ophthalmic solutions
An ophthalmic solutions that are broad ranged and effective in low concentrations relative to state of the art systems. In particular it has been found that ophthalmic solutions comprising 0.00001...
|